XERIS PHARMACEUTICALS INC Business Finance Contracts & Agreements
20 Contracts & Agreements
- Exchange Agreements (1 contract)
- Indenture Agreements (2)
- Investor Rights Agreements (1)
- Loan Agreements (9)
- Note Agreements (1)
- Purchase Agreements (1)
- Stock Agreements (2)
- Underwriting Agreements (3)
- Joinder and Sixth Amendment to Amended and Restated Loan and Security Agreement, dated October 5, 2021, by and among the Registrant, Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on October 5, 2021)
- Second Supplemental Indenture, by and among the Registrant, Xeris Biopharma Holdings, Inc. and U.S. Bank National Association, dated October 5, 2021 (Filed With SEC on October 5, 2021)
- Fifth Amendment to Amended and Restated Loan and Security Agreement (Filed With SEC on August 5, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on March 11, 2021)
- Fourth Amendment to Amended and Restated Loan and Security Agreement, dated as of October 23, 2020, by and among Oxford Finance LLC, Silicon Valley Bank and the Registrant (Filed With SEC on March 9, 2021)
- Form of Exchange Agreement (Filed With SEC on November 16, 2020)
- Third Amendment to Amended and Restated Loan and Security Agreement, dated as of August 5, 2020, by and among Oxford Finance LLC, Silicon Valley Bank and the Registrant (Filed With SEC on November 9, 2020)
- Second Amendment to Amended and Restated Loan and Security Agreement, dated as of June 30, 2020, by and among Oxford Finance LLC, Silicon Valley Bank and the Company (Filed With SEC on August 10, 2020)
- Base Indenture, dated as of June 30, 2020, by and between Xeris Pharmaceuticals, Inc. and U.S. Bank National Association (Filed With SEC on July 1, 2020)
- First Amendment to Amended and Restated Loan and Security Agreement, dated April 21, 2020, by and among Oxford Finance LLC, Silicon Valley Bank and the Company (Filed With SEC on May 7, 2020)
- U.S. Small Business Administration Paycheck Protection Program Note, entered into April 21, 2020 by the Company (Filed With SEC on April 24, 2020)
- Underwriting Agreement, dated February 11, 2020, by and among Xeris Pharmaceuticals, Inc., Jefferies LLC and Piper Sandler & Co (Filed With SEC on February 13, 2020)
- Amended and Restated Loan and Security Agreement, dated as of September 10, 2019, by and between Oxford Finance LLC, Silicon Valley Bank and Xeris Pharmaceuticals, Inc (Filed With SEC on September 10, 2019)
- Second Amendment to Loan and Security Agreement, dated as of May 15, 2019, by and among Oxford Finance LLC, Silicon Valley Bank and the Registrant (Filed With SEC on August 6, 2019)
- Form of Underwriting Agreement (Filed With SEC on February 11, 2019)
- 2018 Employee Stock Purchase Plan (Filed With SEC on June 11, 2018)
- Form of Specimen Common Stock Certificate (Filed With SEC on June 11, 2018)
- Form of Underwriting Agreement (Filed With SEC on June 11, 2018)
- Loan and Security Agreement, dated as of February 28, 2018, by and between Oxford Finance LLC, Silicon Valley Bank and the Registrant (Filed With SEC on May 24, 2018)
- Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated December 31, 2015 (Filed With SEC on May 24, 2018)
